Viomycin - CAS 32988-50-4

Viomycin(CAT: I010821) is a member of the tuberactinomycin family of antibiotics. It acts by inhibiting group I intron splicing, a process involved in RNA maturation, as well as prokaryotic protein synthesis. Viomycin’s mechanism of action is based on its ability to bind to the ribosome and disrupt the translation process, leading to the inhibition of bacterial protein synthesis. Due to its specific mode of action, viomycin is primarily used in the treatment of tuberculosis caused by drug-resistant strains. Its inhibitory effects on intron splicing also make it a valuable tool in molecular biology research.

Catalog Number: I010821

CAS Number: 32988-50-4

PubChem Substance ID:355433437

Molecular Formula: C25H43N13O10

Molecular Weight:685.7

Purity: ≥95%

Online inquiry

* For research use only. Not for human or veterinary use.

Synonym

Synonyms	(S)-3,6-Diamino-N-((3S,9S,12S,15S,Z)3((2R,4S)-6-amino-4-hydroxy-1,2,3,4-tetrahydropyridin-2-yl)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentaazacyclohexadecan-15-yl)hexanamide disulfate

Property

Molecular Formula:	C25H43N13O10
Molecular Weight	685.7
Target:	DNA Synthesis
Solubility	Soluble to 75 mM in water
Purity	≥95%
Storage	Store at -20C

Computed Descriptor

IUPAC Name	(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
InChI	InChI=1S/C25H43N13O10/c26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43/h7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48)/b13-7-/t10-,11+,12-,14-,15-,17-,18-/m0/s1
InChIKey	GXFAIFRPOKBQRV-GHXCTMGLSA-N
SMILES	C1C(NC(=NC1O)N)C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(CCCN)N